AMINOSYN II 7% INJECTION SOLUTION

Nchi: Kanada

Lugha: Kiingereza

Chanzo: Health Canada

Viambatanisho vya kazi:

GLUTAMIC ACID; GLYCINE; HISTIDINE; L-PROLINE; L-LYSINE (L-LYSINE ACETATE); METHIONINE; L-PHENYLALANINE; L-THREONINE; TRYPTOPHAN; L-VALINE; L-ALANINE; L-ARGININE; L-ASPARTIC ACID; SERINE; N-ACETYL-L-TYROSINE; L-ISOLEUCINE; L-LEUCINE

Inapatikana kutoka:

HOSPIRA HEALTHCARE ULC

ATC kanuni:

B05BA01

INN (Jina la Kimataifa):

AMINO ACIDS

Kipimo:

517MG; 350MG; 210MG; 505MG; 735MG; 120MG; 209MG; 280MG; 140MG; 350MG; 695MG; 713MG; 490MG; 371MG; 189MG; 462MG; 700MG

Dawa fomu:

SOLUTION

Tungo:

GLUTAMIC ACID 517MG; GLYCINE 350MG; HISTIDINE 210MG; L-PROLINE 505MG; L-LYSINE (L-LYSINE ACETATE) 735MG; METHIONINE 120MG; L-PHENYLALANINE 209MG; L-THREONINE 280MG; TRYPTOPHAN 140MG; L-VALINE 350MG; L-ALANINE 695MG; L-ARGININE 713MG; L-ASPARTIC ACID 490MG; SERINE 371MG; N-ACETYL-L-TYROSINE 189MG; L-ISOLEUCINE 462MG; L-LEUCINE 700MG

Njia ya uendeshaji:

INTRAVENOUS

Vitengo katika mfuko:

500ML

Dawa ya aina:

Ethical

Eneo la matibabu:

CALORIC AGENTS

Bidhaa muhtasari:

Active ingredient group (AIG) number: 1750888004; AHFS:

Idhini hali ya:

CANCELLED POST MARKET

Idhini ya tarehe:

2016-07-29

Tabia za bidhaa

PRESCRIBING INFORMATION
AMINOSYN
TM II 7%
AMINOSYN
TM II 8.5%
AMINOSYN
TM II 10%
AMINOSYN
TM II 15%
(amino acids for injection 7%, 8.5%, 10% and 15% w/v)
SULFITE-FREE
NUTRITIVE SUPPLEMENT FOR INTRAVENOUS INFUSION
Hospira Healthcare Corporation
DATE OF PREPARATION:
1111 Dr. Frederik-Philips
June 1, 2012
St-Laurent, Quebec
H4M 2X6
Control # 151223
_PRESCRIBING INFORMATION; Aminosyn_
_TM_
_ II 7%, 8.5%, 10 % and 15% _
_Page 2 of 16 _
PRESCRIBING INFORMATION
NAME OF DRUGS
AMINOSYN
TM
II 7%
AMINOSYN
TM
II 8.5%
AMINOSYN
TM
II 10%
AMINOSYN
TM
II 15%
(amino acids for injection 7%, 8.5%, 10% and 15% w/v)
Sulfite-Free
THERAPEUTIC OR PHARMACOLOGICAL CLASSIFICATION
Nutritive Supplement for Intravenous Infusion
ACTIONS AND CLINICAL PHARMACOLOGY
AMINOSYN
7
II 7%, 8.5%, 10% and 15% (amino acids for injection 7%, 8.5%, 10% and
15%)
provides crystalline amino acids which, when administered with
appropriate source of energy,
promote protein synthesis and wound healing and prevent endogenous
protein catabolism.
AMINOSYN
7
II, when given by peripheral or central venous infusion in combination
with
dextrose, electrolytes, vitamins, trace metals and/or ancillary fat
supplements, constitutes Total
Parenteral Nutrition (TPN).
INDICATIONS AND CLINICAL USE
Parenteral nutrition with AMINOSYN
7
II 7%, 8.5%, 10% and 15% is indicated to prevent
nitrogen loss or treat negative nitrogen balance in adults and
children where:
1.
the alimentary tract, by the oral, gastrotomy, or jejunostomy route
cannot or should not
be used, or adequate protein intake is not feasible by these routes;
2.
gastrointestinal absorption of protein is impaired; or
3.
protein requirements are substantially increased as with extensive
burns.
Dosage, route of administration, and concomitant infusion of
non-protein calories are dependent
on various factors, such as nutritional and metabolic status of the
patient, anticipated duration of
parenteral nutritional support, and vein tolerance. (See
DOSAGE AND ADMINISTRATION
for additional information).
_PRESCRIBING INFORMATION; A